Director

Ilan Oren has served as a member of the Board since May, 2020. Ilan also served as Co-Chief Executive Officer of Dexcel Pharma, a privately-owned Israeli group of phar­ma­ceu­ti­cal companies, since November 2019. He is currently on the board of Clexio Biosciences and Roivant Sciences. Prior to serving as Co-CEO, he served as Vice President for the group and led corporate and business development activities, including formation of strategic ventures, product part­ner­ships, product portfolio selection, product acqui­si­tions, strategic investments, and mergers and acqui­si­tions. Ilan holds an AB in Economics from Harvard College.